Resultados de la búsqueda 141-150 of 11354 for Low testosterone
... T cells to recognize B cell specific tumor markers; however, attempts to treat solid tumors with CAR T ... low risk germ cell tumors after their tumor is removed.
The purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with gastric adenocarcinoma with limited low ...
... T cells to recognize B cell specific tumor markers; however, attempts to treat solid tumors with CAR T ... After ILND, patients are defined as being at low or ...
... T-cell (CAR-T) therapy. The most common adverse event after CAR-T therapy is lower than normal blood cells (cytopenia) and up to one third of patients ...
... T therapy are unknown. In addition, relatively little is known about the psychosocial impact of CAR-T on survivors and their caregivers. Due to the ...
The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't approved by the U.S. Food and Drug Administration (FDA). However ...
The AAT protein that usually protects the lungs doesn't work well or there isn't enough. ... And AAT protein with low quantity or quality has either the letter S ...
This is a peripheral blood Collection Protocol to study the T ... A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR- ...
The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't approved by the U.S. Food and Drug Administration (FDA). However, ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?